When was immunitoAI founded?

immunitoAI was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is immunitoAI located?

immunitoAI is headquartered in Bengaluru, India. It is registered at 879, NTI LAYOUT, 2ND PHASE, RAJEEV GANDHI NAGAR, KODIGEHALLI, RAILWAY PARALLEL ROAD, Bangalore, BANGALORE, Karnataka, India, 560097.

Who is the current CEO of immunitoAI?

Aridni Shah of immunitoAI. They have also founded 1 company.

Which legal entities is immunitoAI associated with?

immunitoAI is associated with IMMUNITOAI PRIVATE LIMITED.

How many employees does immunitoAI have?

As of Aug 31, 2025, immunitoAI has 17 employees, reflecting a 22% year-over-year decline in headcount.

Is immunitoAI a funded company?

immunitoAI is a funded company, having raised a total of $7.98M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 05, 2021.

How much is immunitoAI worth?

The latest valuation of immunitoAI is $***** as of Nov 20, 2025.

When was the latest funding round of immunitoAI?

immunitoAI's latest funding was a $***** Series A round on Oct 11, 2025, with participation from 1 investor. Its primary sector is Life Sciences Tech. Globally, the Life Sciences Tech sector has seen $6.18B in funding in 2026 to date.

What is the annual revenue of immunitoAI?

Annual revenue of immunitoAI is less than ₹10 Cr as on Mar 31, 2025

Where does immunitoAI rank among its competitors?

immunitoAI ranks 9th amongst 23 active competitors, of which 13 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Chai Discovery, which secured $400M in Jul, 2026.

Who are the top competitors of immunitoAI?

immunitoAI's top competitors include Chai Discovery, Antiverse and Adimab. Among them, Chai Discovery secured the most recent funding round in July, 2026.

immunitoAI - 2026 Company Profile, Team, Funding, Competitors & Financials

immunitoAI is a series A company based in Bengaluru (India), founded in 2020 by Aridni Shah and Trisha Chatterjee. It operates as a Developer of AI-based platform for antibody discovery and therapeutics. immunitoAI has raised $7.98M in funding from C-CAMP and pi Ventures, with a current valuation of $*****. The company has 23 active competitors, including 13 funded and 2 that have exited. Its top competitors include companies like Chai Discovery, Antiverse and Adimab.

Company Details

Developer of AI-based platform for antibody discovery and therapeutics. The product imRANK screens and ranks antibody sequences to predict the binding strength with an antigen and another product imEVOLVE identifies and mutates regions of antibodies that increase the binding affinity with the antigen.

Website: www.immunitoai.com
Social
Email ID: *****@immunitoai.com
Registered Address: 879, NTI LAYOUT, 2ND PHASE, RAJEEV GANDHI NAGAR, KODIGEHALLI, RAILWAY PARALLEL ROAD, Bangalore, BANGALORE, Karnataka, India, 560097

Key Metrics

Founded Year

2020

Location

Bengaluru, India

Stage

Series A

Total Funding

$7.98M in 6 rounds

Latest Funding Round

Series A, Oct 11, 2025, $*****

Post Money Valuation

$***** as on Nov 20, 2025

Investors

C-CAMP & 32 more

Ranked

9^th among 23 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

17 as on Aug 31, 2025

Similar Companies

OpenEvidence & 2856 more

View immunitoAI's full profile

immunitoAI is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
IMMUNITOAI PRIVATE LIMITED CIN: U72900KA2020PTC141607 , India, Active	Nov 28, 2020	0 - ₹10 Cr (As on Mar 31, 2025)	18 (As on Mar 01, 2026)

immunitoAI has raised a total funding of $7.98M over 6 rounds. Its first funding round was on Mar 05, 2021. Its latest funding round was a Series A round on Oct 11, 2025 for $*****. 1 investor participated in its latest round. immunitoAI has 18 institutional investors and 15 angel investors.

Here is the list of recent funding rounds of immunitoAI:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 11, 2025	3280752	Series A	7869434	9035174	1009789	4369645
Oct 09, 2025	6357712	Series A	8470335	7832053	2185174	pi Ventures & 19 more
Aug 30, 2025	5291374	Seed	6703733	2157677	C-CAMP	4576647

Access funding benchmarks and valuations. Sign up today!

View details of immunitoAI's funding rounds and investors

The founders of immunitoAI are Aridni Shah and Trisha Chatterjee. Aridni Shah is the CEO of immunitoAI.

Here are the details of immunitoAI's key team members:

Aridni Shah: Co-Founder & CEO of immunitoAI. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Trisha Chatterjee: Co-Founder & CTO of immunitoAI. They serve on the board of 1 company.

immunitoAI's Board of Directors

immunitoAI's board has 2 active members. Aridni Shah and Trisha Chatterjee are part of team.

Here is the list of immunitoAI's board of directors:

Name	Type	Representing	Status	Duration
Aridni Shah	Team	-	Current	5y 8m
Trisha Chatterjee	Team	-	Current	5y 8m

View details of immunitoAI's Founder profiles and Board Members

immunitoAI's employee count trend

immunitoAI has 17 employees as of Aug 25. The total employee count is 23.0% lower than what it was in Aug 24. Here is immunitoAI's employee count trend over the years:

Uncover immunitoAI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of immunitoAI include Chai Discovery, Antiverse and Adimab. Here is the list of Top 10 competitors of immunitoAI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Chai Discovery 2023, San Francisco (United States), Series C	Developer of artificial intelligence models for de novo molecular design	$630M	Kleiner Perkins, Sequoia Capital & 28 others	69/100
2nd	Antiverse 2017, Cardiff (United Kingdom), Series A	Developer of computational platform for de novo design of antibody therapeutics	$20M	Kadmos Capital, ACF Investors & 34 others	67/100
3rd	Adimab 2007, Lebanon (United States), Series F	Antibody discovery and optimization platform for autoimmune and infectious diseases	$35.4M	Polaris Partners, SV Health Investors & 10 others	65/100
4th	Apoha 2021, Bolton (United Kingdom), Series A	Developer of sensory intelligence software to seamlessly anchor machines into physical reality to understand and analyze material behavior	$36M	Singular, Draper & 6 others	60/100
5th	BigHat 2019, San Carlos (United States), Series B	Provider of antibody therapies developed by machine learning and synthetic biology	$148M	Andreessen Horowitz, S32 & 13 others	57/100
6th	AbSci 2011, Vancouver (United States), Public	Developer of AI based technology for the production of recombinant protein for therapeutic applications	$228M	Casdin Capital, Redmile Group & 22 others	57/100
7th	LabGenius Therapeutics 2012, London (United Kingdom), Series B	Developer of an automated platform for therapeutic antibody discovery	$69.5M	Obvious Ventures, Atomico & 15 others	56/100
8th	Laigo Biotechnology 2023, Utrecht (Netherlands), Seed	Developer of targeted protein degradation technology for therapeutic applications	$19.8M	Kurma Partners, Curie Capital & 8 others	47/100
9th	immunitoAI 2020, Bengaluru (India), Series A	Developer of AI-based platform for antibody discovery and therapeutics	$7.98M	LetsVenture, Beeline Impex & 31 others	47/100
10th	Ordaos 2019, New York City (United States), Seed	Provider of an AI accelerator for biomedical research and drug discovery	$21.5M	VTC Ventures, IAG Capital Partners & 5 others	47/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on immunitoAI's competitors? Click here to see the top ones

Founders (largest shareholder) own 35.33%, Funds own 33.35%, Enterprises own 0.48% and Angels own 16.81%. The net worth of immunitoAI's founders is INR 74.7Cr as of Nov 20, 2025.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	35.33%	74.7Cr	7227052	6636784	3349142	7864790
Aridni Shah	2827252	9996953	9986446	8768048	1772605	7549941
Trisha Chatterjee	6104484	3399978	4501567	8792763	1777621	9925880
Fund	33.35%	70.5Cr	3202817	9945927	5884627	2250181
pi Ventures	5355284	3964937	1842274	7232588	2761264	8815446
Anicut Capital	44504	52271	21371	42903	90096	24399
LetsVenture	2	2	6	8	6	8
C-CAMP	0	0	0	0	0	0
Enterprise	0.48%	1.01Cr	0	0	0	0
Angel	16.81%	35.5Cr	6659834	9823315	4575124	4823447
Aneesh Venkatadri	0	0	0	0	0	0
Silpa Kode	0	0	0	0	0	0
ESOP Pool	14.03%	29.7Cr	8589454	3707818	3412119	5413473
Total	100.00%	211Cr	7618086	5123167	6026030	8530472